Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

International Islamic University, Islamabad116 enrolled

Overview

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Enrollment

116

Conditions

Erectile Dysfunction

Interventions

Sildenafil Citrate 50Mg TabDRUG

The Group A received sildenafil citrate 50 mg on demand for a period of max 3 months.

Cognitive Behavioral PsychotherapyBEHAVIORAL

The Group B received cognitive behavior psychotherapy for a period of max 3 months.

Combined or Integrated TherapyCOMBINATION_PRODUCT

The Group C received the combined therapeutic approach for a period of max 3 months.

Eligibility

Sex: MALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men diagnosed with erectile dysfunction * Must be in the age range of 18 to 40 years * Must be in a stable heterosexual relationship * Must not be suffering from any medical or psychiatric illness Exclusion Criteria: * Men not meeting criteria of diagnosis of erectile dysfunction * Men not in a heterosexual relationship * Men above the age of 40 years * Men diagnosed with any medical or psychiatric illness

Locations (1)

Ahmad Bilal Private Practice

Chak Four Hundred Fifty-four, Punjab Province, Pakistan

Outcomes

Primary Outcomes

International Index of Erectile Functioning-5

Time frame: 3 months maximum

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.